A non‐toxic analogue of a coeliac‐activating gliadin peptide: a basis for immunomodulation?

Abstract

Peptide F, which binds to DQ2 more strongly than peptide A, is not toxic in patients with coeliac disease in-vitro; this could be an initial step towards investigation of the induction of tolerance to gliadin in patients affected by coeliac disease.